Early Detection Research Network

Lung

YES has not been identified previously in serum as a lung cancer biomarker and represents a novel finding in the aptamer proteomic technology study (Ostroff et al, 2010). YES was observed up-regulated in lung cancer in this study.
http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/501/397
Curated
Two
YES is a member of a 12 protein panel that can discriminate NSCLC from controls with 91% sensitivity and 84% specificity in cross-validated training and 89% sensitivity and 83% specificity in a separate verification set, with similar performance for early and late stage NSCLC.
0047332af278485096ce50b05280ef2f
no
no
Contents

There are currently no items in this folder.